Exempt annuity income from tax, allow systematic withdrawal as an alternative to boost NPS’ popularity: Axis Pension Fund CEO | Simply Save January 17th, 2024 19:27
Given the importance of creating a social security net for Indians, push to NPS in the form of tax benefits is essential, says Sumit Shukla, MD and CEO, Axis Pension Fund

Maxposure IPO subscribed 904.82 times, retail portion booked 1,049 times on final day January 17th, 2024 18:27
Maxposure IPO | The company will finalise the basis of allotment by January 18 and the shares will be credited to the demat accounts of eligible investors by January 19

Technical View | Nifty forms bearish candle, Bank Nifty remains a worry January 17th, 2024 18:27
The options data indicates that 21,500 is expected to be the immediate support for the index and 21,700-21,800 the likely hurdle

Gainers and Losers: 10 stocks that moved the most on January 17 January 17th, 2024 17:30
All sectors except information technology ended in the red. Banking index was the worst hit and was down 4 percent.

Maxposure IPO subscribed 838.5 times, retail portion booked 961 times on final day January 17th, 2024 17:30
Maxposure IPO | The company will finalise the basis of allotment by January 18 and the shares will be credited to the demat accounts of eligible investors by January 19

Asian Paints#39; growth supported by extended festive season, says CEO Amit Syngle January 17th, 2024 17:30
In the Home Décor space, the company had a more favorable quarter, with new categories gaining traction.

Budget 2024: MTaI seeks lowering of customs duty, removal of health cess on medical devices January 17th, 2024 17:30
The Medical Technology Association of India on January 17 sought the lowering of customs duty to 2.5 percent and the removal of health cess ad valorem on medical devices in the upcoming Union Budget.

Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease January 17th, 2024 17:30
Under the terms of the agreement, Bayer has granted non-exclusive rights to Sun Pharma to market and distribute a second Finerenone product under the brand name Lyvelsa.

Jio, Reliance Retail to steal the show in RIL’s report card for Q3? January 17th, 2024 17:30
Retail and Jio will account for 95 percent of EBITDA growth over the next three years, according to analysts.

Axar Patel, Yashaswi Jaiswal break into top 10 of ICC T20I rankings January 17th, 2024 17:30
Opening batter Yashasvi Jaiswal rose to the sixth spot in the latest ICC men#39;s T20I player rankings